Common gastrointestinal side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain
Specifically, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonists are pivotal in managing appetite control, regulating blood sugar, and promoting fat metabolism
Historically, offer rates have been lower among firms with 3 to 9 employees
Monitor appetite, cravings and weight weekly and body composition every 4 to 6 weeks
This intravenous treatment is a specialized approach designed to alleviate arthritis symptoms, such as inflammation, joint pain, and stiffness
Ribar TJ, Rodriguiz RM, Khiroug L, Wetsel WC, Augustine GJ, Means AR